Westshore Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-206
Closed -$221K 111
2025
Q4
$221K Buy
+206
New +$197K 0.07% 92
2025
Q2
Sell
-247
Closed -$204K 99
2025
Q1
$204K Buy
+247
New +$206K 0.09% 89
2024
Q3
Sell
-226
Closed -$205K 99
2024
Q2
$205K Buy
+226
New +$181K 0.09% 90
2021
Q3
Sell
-2,937
Closed -$674K 112
2021
Q2
$674K Hold
2,937
0.35% 44
2021
Q1
$549K Buy
+2,937
New +$575K 0.31% 53

Other funds holding LLY

Westshore Wealth's LLY Position: Q1 2026 in Review

Westshore Wealth sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 206 shares — an estimated $221K sold.

Westshore Wealth first reported a position in LLY in Q1 2021 and held it in 5 quarters. The position peaked at $674K in Q2 2021. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Westshore Wealth reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Westshore Wealth sold 206 Eli Lilly shares in Q1 2026, an estimated $221K.
  • Westshore Wealth first reported a position in Eli Lilly in Q1 2021 and held it in 5 quarters.
  • Westshore Wealth's Eli Lilly position peaked at $674K in Q2 2021.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Westshore Wealth's 13F filing for Q1 2026, filed 27 May 2026.